Literature DB >> 21842364

Bridging innate NK cell functions with adaptive immunity.

Emanuela Marcenaro, Simona Carlomagno, Silvia Pesce, Alessandro Moretta, Simona Sivori.   

Abstract

Killer Ig-like receptors (KIRs) are major human NK receptors displaying either inhibitory or activating functions which recognize allotypic determinants of HLA-class I molecules. Surprisingly, NK cell treatment with CpG-ODN (TLR9 ligands) results in selective down-modulation of KIR3DL2, its co-internalization with CpG-ODN and its translocation to TLR9-rich early endosomes. This novel KIR-associated function may offer clues to better understand the possible role of certain KIRs and also emphasizes the involvement of NK cells in the course of microbial infections. NK cells are involved not only in innate immune responses against viruses and tumors but also participate in the complex network of cell-to cell interaction that leads to the development of adaptive immune responses. In this context the interaction of NK cells with DC appears to play a crucial role in the acquisition of CCR7, a chemokine receptor that enables NK cells to migrate towards lymph nodes in response to CCL19 and/or CCL21. Analysis of NK cell clones revealed that KIR-mismatched but not KIR-matched NK cells acquire CCR7. These data have important implications in haploidentical haematopoietic stem cell transplantation (HSCT), in which KIR-mismatched NK cells may acquire the ability to migrate to secondary lymphoid compartments (SLCs), where they can kill recipient's antigen presenting cells (APCs) and T cells thus preventing graft versus host (and host vs. graft) reactions.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21842364     DOI: 10.1007/978-1-4419-5632-3_5

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  16 in total

1.  HLA-F and MHC class I open conformers are ligands for NK cell Ig-like receptors.

Authors:  Jodie P Goodridge; Aura Burian; Ni Lee; Daniel E Geraghty
Journal:  J Immunol       Date:  2013-09-09       Impact factor: 5.422

Review 2.  In Vitro Models for Studying Respiratory Host-Pathogen Interactions.

Authors:  Sarah L Barron; Janire Saez; Róisín M Owens
Journal:  Adv Biol (Weinh)       Date:  2021-05-04

3.  New perspectives on the ligands and function of the killer cell immunoglobulin-like receptor KIR3DL2 in health and disease.

Authors:  Jacqueline Shaw; Simon Kollnberger
Journal:  Front Immunol       Date:  2012-11-16       Impact factor: 7.561

Review 4.  TLR/NCR/KIR: Which One to Use and When?

Authors:  Simona Sivori; Simona Carlomagno; Silvia Pesce; Alessandro Moretta; Massimo Vitale; Emanuela Marcenaro
Journal:  Front Immunol       Date:  2014-03-19       Impact factor: 7.561

5.  Definition of the cattle killer cell Ig-like receptor gene family: comparison with aurochs and human counterparts.

Authors:  Nicholas D Sanderson; Paul J Norman; Lisbeth A Guethlein; Shirley A Ellis; Christina Williams; Matthew Breen; Steven D E Park; David A Magee; Farbod Babrzadeh; Andrew Warry; Mick Watson; Daniel G Bradley; David E MacHugh; Peter Parham; John A Hammond
Journal:  J Immunol       Date:  2014-11-14       Impact factor: 5.422

6.  Longitudinal investigation of natural killer cells and cytokines in chronic fatigue syndrome/myalgic encephalomyelitis.

Authors:  Ekua W Brenu; Mieke L van Driel; Donald R Staines; Kevin J Ashton; Sharni L Hardcastle; James Keane; Lotti Tajouri; Daniel Peterson; Sandra B Ramos; Sonya M Marshall-Gradisnik
Journal:  J Transl Med       Date:  2012-05-09       Impact factor: 5.531

7.  Lipopolysaccharide Attenuates CD40 Ligand-Induced Regulatory B10 Cell Expansion and IL-10 Production in Mouse Splenocytes.

Authors:  Mei Lin; Jiang Lin; Yuhua Wang; Nathalie Bonheur; Toshihisa Kawai; Zuomin Wang; Xiaozhe Han
Journal:  Open J Immunol       Date:  2015-03

8.  Blocking KCa3.1 channels increases tumor cell killing by a subpopulation of human natural killer lymphocytes.

Authors:  Shyny Koshy; Danli Wu; Xueyou Hu; Rajeev B Tajhya; Redwan Huq; Fatima S Khan; Michael W Pennington; Heike Wulff; Patricia Yotnda; Christine Beeton
Journal:  PLoS One       Date:  2013-10-11       Impact factor: 3.240

9.  Natural killer cell-dependent anti-fibrotic pathway in liver injury via Toll-like receptor-9.

Authors:  Lina Abu-Tair; Jonathan H Axelrod; Sarit Doron; Yossi Ovadya; Valery Krizhanovsky; Eithan Galun; Johnny Amer; Rifaat Safadi
Journal:  PLoS One       Date:  2013-12-10       Impact factor: 3.240

10.  Standardization of whole blood immune phenotype monitoring for clinical trials: panels and methods from the ONE study.

Authors:  Mathias Streitz; Tewfik Miloud; Michael Kapinsky; Michael R Reed; Robert Magari; Edward K Geissler; James A Hutchinson; Katrin Vogt; Stephan Schlickeiser; Anders Handrup Kverneland; Christian Meisel; Hans-Dieter Volk; Birgit Sawitzki
Journal:  Transplant Res       Date:  2013-10-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.